Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
IL-2 for CD4 Preservation in HIV Treatment Interruption
NCT00071890Phase 2Completed
- Sponsor
- National Institute of Allergy and Infectious Diseases
- Start
- Oct 2003
- Primary completion
- Dec 2007
- Modality
- Cytokines & Interferons
- Countries
- 2
01
Overview
A Phase 2 trial of aldesleukin in human immunodeficiency virus infection (HIV), sponsored by National Institute of Allergy and Infectious Diseases. Started Oct 2003; status: completed.
02
Drugs
aldesleukin
03
Conditions
human immunodeficiency virus infection (HIV)
Beyond the preview
Go deeper on NCT00071890.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00071890.